REFERENCES
- Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, et al. Epidemiology of DSM-5 alcohol use disorder: Results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry. 2015;72(8):757–766.
- Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA. 2006;295(17):2003–2017.
- Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, et al. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005;25(4):349–357.
- Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. JAMA. 2014;311(18):1889–1900.
- Swift R, Aston E. Pharmacotherapy for alcohol use disorder: Current and Emerging Therapies. Harv Rev Psychiatry. 2015;23(2):122–133.
- Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, et al. The american psychiatric association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018;175(1):86–90.
- Center for Substance Abuse Treatment. Services in Intensive Outpatient Treatment Programs. In: Treatment Improvement Protocol (TIP) Series, No. 47. US Department of Health and Human Services, 2007.
- Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–157.
- Finlay A, Ellerbe L, Wong J, Timko C, Rubinsky A, Gupta S, Bowe T, Burden J, Harris A. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs. J Subst Abuse Treat. 2017;77:38–43
- American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance. Am J Health-Syst Pharm. 2016;73(9):e267–70.
- Perez A, Doloresco F, Hoffman J, Meek P, Touchette D, Vermeulen L, et al. Economic evaluations of clinical pharmacy services: 2001–2005. Pharmacotherapy. 2009;29(1):128.
- Touchette DR, Doloresco F, Suda KJ, Perez A, Turner S, et al. Economic evaluations of clinical pharmacy services: 2006–2010. Pharmacotherapy. 2014;34(8):771–793.